softwave | Media Room | PressRelease.com

Press Release May 4, 2023

Chris Holt Takes the Helm as New CEO of SoftWave Tissue Regeneration Technologies, Ushering in a New Era of Growth

Amazon Healthcare veteran Chris Holt brings experience and a bold vision to lead SoftWave TRT's market expansion and product innovation efforts.

Press Release Dec 22, 2021

SoftWave Tissue Regeneration Technologies Enters Exclusive Distribution Agreement With Cynosure to Sell Technology in the Aesthetics and Sexual Health Markets

Exclusive North American Agreement

Press Release May 19, 2021

SoftWave Tissue Regeneration Technologies Receives FDA Clearance for Blood Circulation Increase, Minor Aches and Pains Relief and Connective Tissue Activation

Extracorporeal shock wave device offers healthcare professionals another treatment option

Press Release Sep 1, 2020

SoftWave® Tissue Regeneration Technologies Receives FDA Clearance for the Treatment of Burn Wounds

Press Release Aug 19, 2020

Softwave® Tissue Regeneration Technologies Announces Landmark Trial for Acute Traumatic Spinal Cord Injuries

Press Release Aug 6, 2020

SoftWave Tissue Regeneration Technologies Announces Plan for Cellulite Trial

Press Release Apr 11, 2020

TISSUE REGENERATION TECHNOLOGIES Announces That Its First Coronavirus Clinical Trial Has Been Initiated Utilizing Unfocused Shockwave Therapy (SoftWaves®)

Additionally, TRT has filed a second patent in the war Against COVID 19. The patent is for the treatment of lung (and other organ) disorders and diseases such as COVID-19 and COPD with shockwaves to treat the virus and avert mortality in order to accelerate the recovery of afflicted patients.